Latest Breaking News On - Charles theuer - Page 1 : comparemela.com

TRACON Pharmaceuticals, Inc (NASDAQ:TCON) Q1 2024 Earnings Call Transcript

TRACON Pharmaceuticals, Inc (NASDAQ:TCON) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Charles theuerJim molloyMatt veneziaMatthew veneziaJames molloyScott brownAlliance global partnersPharmaceuticals first quarterHearings panelSecurities exchange commissionNational cancer instituteTracon pharmaceuticals incCall transcript mayFirst quarterChief financial officerFast track

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesCharles theuerBrian ritchieCompany contactLifesci advisors

TRACON Pharmaceuticals Announces Reverse Stock Split

SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a.

United statesCharles theuerBrian ritchieLifesci advisorsCompany the boardCompany contactProduct development platformExchange commissionCompany boardEquiniti trust companyRestated certificateNasdaq capital marketPrivate securities litigation reform actNasdaq tconTracon pharmaceuticals

TRACON Pharmaceutical (TCON) Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial

TRACON Pharmaceutical (TCON) Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCharles theuerTracon pharmaceuticalsDrug administrationAlphamab oncology

TRACON Pharmaceutical (TCON) Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned

TRACON Pharmaceutical (TCON) Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Charles theuerTracon pharmaceuticalsJames freddo